Septerna (SEPN) Current Deferred Tax Assets (2023 - 2025)

Septerna's (SEPN) quarterly Current Deferred Tax Assets came in at $39000.0 in Q2 2025, little changed quarter-over-quarter from $39000.0 in Q1 2025.

Septerna (SEPN) Current Deferred Tax Assets (2023 - 2025) Analysis & Trends

Septerna's Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $39000.0 for Q2 2025.

On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $39000.0 in Q2 2025; TTM through Jun 2025 was $39000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $39000.0, down 48.0% from the prior year.
Current Deferred Tax Assets held at $39000.0 in Q2 2025 per SEPN's latest filing, from $39000.0 in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $232000.0 in Q3 2024 and bottomed at $39000.0 in Q4 2024.
The 3-year median for Current Deferred Tax Assets is $39000.0 (2024), against an average of $84800.0.
Biggest YoY gain for Current Deferred Tax Assets was 48.0% in 2024; the steepest drop was 48.0% in 2024.
Year by year, Current Deferred Tax Assets stood at $75000.0 in 2023, then plunged by 48.0% to $39000.0 in 2024, then changed by 0.0% to $39000.0 in 2025.
Per Business Quant, the three latest SEPN Current Deferred Tax Assets figures stand at $39000.0 (Q2 2025), $39000.0 (Q1 2025), and $39000.0 (Q4 2024).

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Septerna	1.50 Bn	1.50 Bn	-

Download Data